DELIVERING ON THE PROMISE OF PURITY
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 27 Apr 2027, and its filing window is open now).
Record
- Serial number
- 87619909
- Registration number
- 6335374
- Mark type
- Slogan / phrase
- Filed
- 23 Sept 2017
- Published for opposition
- 24 Mar 2020
- Registered
- 27 Apr 2021
- Next maintenance filing
- §8 declaration of use, due by 27 Apr 2027 (grace period to 27 Oct 2027)
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 001 — Chemicals: Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Owner
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
Prosecution history
- 27 Apr 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Feb 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Dec 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Dec 2020 — NON-FINAL ACTION E-MAILED
- 22 Dec 2020 — SU - NON-FINAL ACTION - WRITTEN
- 02 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Nov 2020 — USE AMENDMENT FILED
- 01 Dec 2020 — SOU EXTENSION 1 GRANTED
- 17 Nov 2020 — SOU EXTENSION 1 FILED